Ask AI

On-Demand Webcast

Share

Program Content

Activities

  • Immunotherapy Options in HNSCC
    Driving Progress in HNSCC: Integrating Immunotherapy and Novel Targeted Therapies Across the Disease Continuum
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 05, 2025

    Expires: December 04, 2025

Provided by

ProCE Banner

Supporters

Coherus BioSciences, Inc.

Merck Sharp & Dohme Corp.